| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |